Controlling the entire pharmaceutical value chain
allows us to establish new standards for cannabinoid therapies

Verified HCP access · QA/QP interfaces · Batch traceability · Continuing education for healthcare professionals

The gap between global innovation and local patient care

By merging research and logistics, we offer professionals a portfolio that is scientifically sound, regulatory-compliant, and operationally reliable. We deliver not just products, but the sovereignty for the medicine of tomorrow.

For you, process clarity is important Basis for reliable supply:

Documented interfaces, traceability, and predictable processing. MediFirst provides a fully integrated system for this.

Operational safety at every process stage through vertical integration of our value chain

We provide validated system depth as a modular infrastructure for your pharmaceutical requirements.

Portal for healthcare professionals

Product portfolio 

For pharmacies and hospital pharmacies: Here, verified healthcare professionals receive comprehensive information about our products and usage contexts.

To the HCP portal — Request access

Placing on the market (EU)

Regulatory security for your EU market entry.

Assuming responsibility as the pharmaceutical entrepreneur (MAH). We manage import, QP release, and compliance for your innovations.

Request a project — Learn more

Global Trade

Scalable infrastructure for global pharma trade

B2B-Handel und Distribution unter Einhaltung der GDP-Richtlinien – mit dokumentierten Übergaben und Traceability.

Request a project — Learn more

Mission

Access to the best possible care is not a privilege for us, but a fundamental right.

Because we are convinced that only precise, quality-assured care is sustainable in the long term and consistently reduces mis-supply, we reverse the pharmaceutical logic: We start with patient need and build the entire chain backwards - from evidence and specification through quality assurance to distribution at the point of care. We work according to the MediFirst reverse-engineering approach.

Learn more now
The MediFirst Quality Loop shows how we combine evidence, quality assurance, and distribution in a closed system.

Vertikale Integration für Präzisionsmedizin:
Ein geschlossener Kreislauf für verlässliche Therapiesicherheit

Patient-centered development

We translate clinical real-world evidence into defined target profiles. From this, we derive the intended cannabinoid/terpene profile as a pharmaceutical specification (reverse engineering)

Proprietary research & genetics

MediFirst R&D and biotech units develop defined chemotypes as a controlled starting basis - aligned with the Swiss research axis (Innuana)."

Technological realization

Implementation is carried out via a qualified partner network under GACP/GMP framework conditions - with controlled process parameters and documented interfaces.

Pharmaceutical integrity

As the pharmaceutical entrepreneur, we take responsibility for QA/QP governance: batch testing, specification conformity, and documented release along defined quality processes.

Pharmaceutical logistics

Distribution under a GDP framework: documented handovers, traceability, and controlled supply-chain interfaces to the point of care - operationally connected to the HCP portal.

For us, therapy safety is not created by promises, but by a robust quality system. MediFirst takes responsibility for defined QA/QP interfaces, documented batch processes, and traceability along the supply chain. Distribution is carried out via a GDP-certified system with controlled handovers to the point of care - product- and order-related evidence is available in the verified HCP portal.

Discover more about Quality & ResponsibilityGet to know the MediFirst Group

Continuing education & knowledge transfer for healthcare professionals

Evidence-oriented trainings on cannabinoid-based therapies. Provided via the MediFirst NPO.

The trainings convey practical specialist knowledge for physicians and pharmacists - up to date with current science and prepared compliantly. The focus is on legal framework conditions, pharmaceutical process quality, and decision confidence in consultation, dispensing, and care processes.

To the continuing education offered by MediFirst NPO